AGYTF
Allergy Therapeutics plc
Set alert
- YTD
- +36.36%
- 1 year
- +36.36%
- Open
- 0.15
- Prev close
- 0.15
- Mkt cap
- 949.88M
- Vol
- 7.14K
- Avg vol
- 0
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.15
- High
- 0.15
- Earnings
- Feb 4, 2025
News
3 months ago proactiveinvestors.com
Boston Scientific beats second quarter expectations, raises full-year outlook
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while...
3 months ago proactiveinvestors.com
Allergy Therapeutics reports accelerated revenue growth in its second half
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further...
3 months ago proactiveinvestors.co.uk
Allergy Therapeutics reports accelerated revenue growth in its second half
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) told investors that revenue growth accelerated in its second half and has guided for a further step-up in the current year as Grassmuno enters…
3 months ago proactiveinvestors.com
Allergy Therapeutics names Helge Weiner-Trapness as executive chair
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology...
3 months ago proactiveinvestors.co.uk
Allergy Therapeutics names Helge Weiner-Trapness as executive chair
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) has appointed former HSBC banker Helge Weiner-Trapness as executive chairman as the biotechnology group explores a potential dual primary…
4 months ago proactiveinvestors.com
FTSE 100 Live: London stocks surge, Wall St volatile as SpaceX trading nears
FTSE 100 jumps 162 points to 10,466 Brent crude futures fall then rise UK economy contracts 0.1% in April Housebuilders show strong recovery 4.17pm:...
4 months ago proactiveinvestors.co.uk
Allergy Therapeutics to showcase pollen and food allergy progress
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) said it will use Europe's flagship allergy and clinical immunology congress to showcase progress across its pollen and food allergy pipeline,…
4 months ago proactiveinvestors.com
Allergy Therapeutics to showcase pollen and food allergy progress
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) said it will use Europe’s flagship allergy and clinical immunology congress to showcase progress...
7 months ago proactiveinvestors.com
Amazon and Delta announce agreement to offer improved in-flight Wifi
Amazon.com Inc (NASDAQ:AMZN) and Delta Air Lines Inc (NYSE:DAL) have announced a new multi-year agreement aimed at enhancing in-flight internet connectivity...
7 months ago proactiveinvestors.com
Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker
A successful rollout of its newly launched grass-pollen treatment is ste put Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) on the path to...
7 months ago proactiveinvestors.co.uk
Grassmuno rollout to put Allergy Therapeutics on path to sustainable profitability, says broker
A successful rollout of its newly launched grass-pollen treatment is ste put Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU) on the path to self-sustaining profitability. That's according to…
7 months ago proactiveinvestors.co.uk
Allergy Therapeutics targets accelerating Grassmuno sales as peanut vaccine advances to next trial phase
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the immunotherapy company, expects commercial momentum to build through the second half of its financial year as its newly launched Grassmuno…
7 months ago proactiveinvestors.com
Dow set to jump as easing Middle East tensions lift Wall Street futures
8:15am: Cooling tensions US stocks were set for a strong open on Tuesday as easing geopolitical tensions lifted sentiment. Dow Jones and S&P 500 futures...
8 months ago proactiveinvestors.com
General Mills recovery likely multiyear, Jefferies says
General Mills Inc (NYSE:GIS, XETRA:GRM) shares remain under pressure as it faces continued volume declines in North America Retail (NAR) and limited...
8 months ago proactiveinvestors.co.uk
Allergy Therapeutics peanut vaccine shows strong immune response in early trial
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed…
8 months ago proactiveinvestors.com
Allergy Therapeutics peanut vaccine shows strong immune response in early trial
AIM-listed biotech reports biomarker results suggesting its VLP Peanut treatment could work in as few as three injections Allergy Therapeutics PLC (AIM:AGY,...
8 months ago proactiveinvestors.co.uk
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF, FRA:HHU), the AIM-listed…
8 months ago proactiveinvestors.com
Allergy Therapeutics reports positive data across grass pollen and peanut allergy programmes
The AIM-listed immunotherapy specialist will present three posters at the AAAAI Annual Meeting in Philadelphia this week Allergy Therapeutics PLC (AIM:AGY,...
9 months ago proactiveinvestors.com
Lululemon price target slashed on outgoing CEO’s final day
Jefferies analysts lowered their price target on Lululemon Athletica Inc (NASDAQ:LULU) stock to $185 from $200, coinciding with the outgoing CEO Calvin...
9 months ago proactiveinvestors.com
FTSE 100 Live: London stocks recover as markets await Fed chair nomination
FTSE 100 gains 13 points to 10,185 Gold, silver and copper retreat from recent highs Fed chair nomination expected today US index futures sink 10.25am:...